Guidelines

Highlights in Non-Hodgkin’s Lymphoma

September 2015
Prevention of febrile neutropenia with prophylactic G-CSF improves outcome

September 2015
Immunotherapy: a new era in the management of lymphoma and multiple myeloma?

September 2015
Nivolumab is safe and effective in patients with relapsed/refractory lymphoid malignancies and classical Hodgkin lymphoma

September 2015
Multiple myeloma is different in elderly patients

September 2015
Adding elotuzumab to standard treatment for multiple myeloma delays disease progression

September 2015
Carfilzomib-dexamethasone: a new ‘best in class’ in multiple myeloma

September 2015
Luspatercept increases hemoglobin and decreases the transfusion need in patients with low-, and intermediate-1 myelodysplastic syndrome

September 2015
JAK2 inhibitor pacritinib significantly benefits patient reported outcomes in myelofibrosis

September 2015
New treatment options for patients with inadequately controlled polycythemia vera

September 2015

Top